“…Approval for pediatric use was based on the results of a Phase III, double-blind, randomized, placebo-controlled, multicenter trial (5). Overall, zonisamide was shown to be effective and well tolerated in this setting, and no new or unexpected safety findings were observed (5,6). Overall, zonisamide was shown to be effective and well tolerated in this setting, and no new or unexpected safety findings were observed (5,6).…”